Literature DB >> 15094084

Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus.

Francois Trudeau1, Sylvain Gagnon, Guy Massicotte.   

Abstract

Diabetes mellitus is an endocrine disorder of carbohydrate metabolism resulting primarily from inadequate insulin release (Type 1 insulin-dependent diabetes mellitus) or insulin insensitivity coupled with inadequate compensatory insulin release (Type 2 non-insulin-dependent diabetes mellitus). Previous studies involving behavioural and electrophysiological analysis indicate that diabetes mellitus induces cognitive impairment and defects of long-term potentiation in the hippocampus. Considered to be an important mechanism of learning and memory in mammals, long-term potentiation is known to require regulation of the glutamate receptor properties. According to many studies, defects of long-term potentiation in the hippocampus of diabetic animals are due to abnormal glutamate receptors. We review here the changes in glutamate receptors that may account for modifications of long-term potentiation in various models of diabetes mellitus. As glutamate receptors are also involved in the appearance of neurodegenerative states, we discuss the possibility that deficits in long-term potentiation during chronic diabetes might arise from dysfunction of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors in early stages of the disease. This review addresses the possible role of hyperglycaemia and insulin in regulating these receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094084     DOI: 10.1016/j.ejphar.2004.02.055

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  39 in total

Review 1.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

2.  Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes.

Authors:  Sukhdev Singh Kamboj; Kanwaljit Chopra; Rajat Sandhir
Journal:  Metab Brain Dis       Date:  2008-09-19       Impact factor: 3.584

3.  Neuroprotective properties of aucubin in diabetic rats and diabetic encephalopathy rats.

Authors:  Hong Yu Xue; Ya Nan Lu; Xue Mei Fang; Yong Ping Xu; Gui Zhen Gao; Li Ji Jin
Journal:  Mol Biol Rep       Date:  2012-07-19       Impact factor: 2.316

4.  Diabetes and the link between neuroplasticity and glutamate in the aging human motor cortex.

Authors:  Peter J Fried; Alvaro Pascual-Leone; Nicolas R Bolo
Journal:  Clin Neurophysiol       Date:  2019-06-21       Impact factor: 3.708

5.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

6.  Reduced hippocampal cell differentiation in the subgranular zone of the dentate gyrus in a rat model of type II diabetes.

Authors:  In Koo Hwang; Sun Shin Yi; Yo Na Kim; Il Yong Kim; In Se Lee; Yeo Sung Yoon; Je Kyung Seong
Journal:  Neurochem Res       Date:  2007-08-22       Impact factor: 3.996

7.  Acute Hyperglycemia Increases Brain Pregenual Anterior Cingulate Cortex Glutamate Concentrations in Type 1 Diabetes.

Authors:  Nicolas R Bolo; Alan M Jacobson; Gail Musen; Matcheri S Keshavan; Donald C Simonson
Journal:  Diabetes       Date:  2020-04-15       Impact factor: 9.461

8.  Effect of sesamol on diabetes-associated cognitive decline in rats.

Authors:  Anurag Kuhad; Kanwaljit Chopra
Journal:  Exp Brain Res       Date:  2007-10-23       Impact factor: 1.972

9.  Diabetic hyperglycemia aggravates seizures and status epilepticus-induced hippocampal damage.

Authors:  Chin-Wei Huang; Juei-Tang Cheng; Jing-Jane Tsai; Sheng-Nan Wu; Chao-Ching Huang
Journal:  Neurotox Res       Date:  2009-02-18       Impact factor: 3.911

10.  Diabetes changes the levels of ionotropic glutamate receptors in the rat retina.

Authors:  Ana R Santiago; Joana M Gaspar; Filipa I Baptista; Armando J Cristóvão; Paulo F Santos; Willem Kamphuis; António F Ambrósio
Journal:  Mol Vis       Date:  2009-08-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.